Musaffa Logo
Blau Farmaceutica SA BLAU3.SA

Last Updated: Jul 17, 12:00 AM·BOVESPA

Blau Farmaceutica SA

Blau Farmaceutica SA. Stock Analysis BLAU3.SA

Brazil Health Care Small Cap
Blau Farmacêutica SA engages in manufacturing of pharmaceuticals. The company is headquartered in Cotia, Sao Paulo. The company went IPO on 2021-04-19. The firm focuses on the development, production and commercialization of medicines, which aim at treatment in the areas of oncology, nephrology, hematology and infectology, among others. Its product lines includes biopharmaceuticals, biosimilars, oncological - injectable, oncological - oral, blood products, antiviral and antiretrovirals, uterine stimulators, anaesthetics, antithrombotics, thrombolytics, female health care, antibiotics, non-beta lactams, cephalosporin, chloramphenicol, acid pumper inhibitor and other hospital products. The firm operates in Brazil, Argentina, Colombia, Peru, Uruguay, Chile and the United States, having a pharmaceutical industrial complex composed of five industrial plants, dedicated to the production of biological, biotechnological and oncological medicines, antibiotics, injectable anesthetics and biotechnological inputs.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!